$0.43 EPS Expected for CONMED Corporation (CNMD)

April 11, 2018 - By Ellis Scott

CONMED Corporation (NASDAQ:CNMD) LogoInvestors sentiment decreased to 1.3 in 2017 Q4. Its down 0.04, from 1.34 in 2017Q3. It turned negative, as 7 investors sold CONMED Corporation shares while 46 reduced holdings. 25 funds opened positions while 44 raised stakes. 26.91 million shares or 0.87% less from 27.14 million shares in 2017Q3 were reported.
185 were accumulated by Delta Asset Limited Co Tn. California State Teachers Retirement Systems owns 0% invested in CONMED Corporation (NASDAQ:CNMD) for 43,283 shares. Fisher Asset Mgmt Lc invested in 0.04% or 615,878 shares. Moreover, Krensavage Asset Lc has 2.61% invested in CONMED Corporation (NASDAQ:CNMD) for 164,547 shares. Peak6 Invs Lp owns 761 shares. Retail Bank Of America De owns 68,985 shares. Alliancebernstein Lp holds 0% or 82,227 shares. Pnc Grp Inc accumulated 671 shares. Parametric Portfolio Assocs Ltd Limited Liability Company holds 0% or 67,936 shares in its portfolio. Moreover, Westwood Hldg Grp has 0.14% invested in CONMED Corporation (NASDAQ:CNMD). Laurion Cap L P has 5,900 shares. Moreover, State Of Wisconsin Invest Board has 0.02% invested in CONMED Corporation (NASDAQ:CNMD) for 127,562 shares. United Kingdom-based Barclays Public Ltd has invested 0% in CONMED Corporation (NASDAQ:CNMD). Royal State Bank Of Canada, Ontario – Canada-based fund reported 15,886 shares. Piedmont Inv reported 0.01% stake.

Since January 3, 2018, it had 1 insider purchase, and 5 selling transactions for $2.91 million activity. Shares for $7,996 were bought by Farkas Charles. The insider POMILIO LUKE A sold 20,345 shares worth $1.22 million. On Friday, March 9 Berge Terence M sold $241,574 worth of CONMED Corporation (NASDAQ:CNMD) or 3,868 shares.

Analysts expect CONMED Corporation (NASDAQ:CNMD) to report $0.43 EPS on April, 25.They anticipate $0.05 EPS change or 13.16 % from last quarter’s $0.38 EPS. CNMD’s profit would be $12.03M giving it 35.97 P/E if the $0.43 EPS is correct. After having $0.69 EPS previously, CONMED Corporation’s analysts see -37.68 % EPS growth. The stock increased 0.86% or $0.53 during the last trading session, reaching $61.87. About 143,453 shares traded. CONMED Corporation (NASDAQ:CNMD) has risen 46.44% since April 11, 2017 and is uptrending. It has outperformed by 34.89% the S&P500.

CONMED Corporation (NASDAQ:CNMD) Ratings Coverage

Among 3 analysts covering Conmed Corp (NASDAQ:CNMD), 1 have Buy rating, 0 Sell and 2 Hold. Therefore 33% are positive. Conmed Corp had 5 analyst reports since November 3, 2017 according to SRatingsIntel. The firm has “Hold” rating by KeyBanc Capital Markets given on Friday, November 3. On Thursday, February 1 the stock rating was maintained by Needham with “Buy”. Needham maintained CONMED Corporation (NASDAQ:CNMD) on Friday, November 17 with “Buy” rating. The firm has “Hold” rating by Piper Jaffray given on Friday, November 3. Piper Jaffray maintained CONMED Corporation (NASDAQ:CNMD) on Thursday, February 1 with “Hold” rating.

CONMED Corporation, a medical technology company, develops, makes, and sells surgical devices and related equipment for minimally invasive procedures in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company has market cap of $1.73 billion. The firm offers sports medicine products, such as powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, metal and bio absorbable implants, and related disposable products and fluid management systems; powered surgical instruments for use in large and small bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, plastic, ENT, neurological, spinal, and cardiothoracic surgeries; and sports biologics and tissues. It has a 31.41 P/E ratio. It also provides electrosurgical generators, hand pieces, smoke management systems, and accessories for surgical needs; and endomechanical instrumentation products that offer various instruments comprising trocars, suction irrigation devices, graspers, scissors, and dissectors used in the minimally invasive laparoscopic and gynecological surgery, as well as an uterine manipulator for use in the laparoscopic hysterectomies and other gynecologic laparoscopic procedures.

CONMED Corporation (NASDAQ:CNMD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.